home1_b

TRIANNI and Antibody Discovery

Fully human monoclonal antibodies are powerful biological therapeutics.

Among many options available for isolating them, TRIANNI’s technology is distinguished by key advantages of ease of use, antibody diversity, and in vivo selection.

partnering
events

ChinaBio® Partnering Forum 2016

May 18–19, 2016 | Suzhou, China

Americas Antibody Congress

May 19-20, 2016 | San Diego, CA